CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 37 enrolled
Drug / intervention
1540 nanometer Erbium glass laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03392935
NCT03392935N/ACompleted
CompareCT.gov

Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign Dermatofibromas

University of Utah·interventional·Posted Jan 8, 2018·Updated May 8, 2023

In Brief

A clinical study evaluating 1540 nanometer Erbium glass laser for Dermatofibroma of Skin. Completed, enrolled 37 participants across 1 site.

Detailed Summary

This study is to find a more effective treatment for itchy, painful or unsightly dermatofibromas, that will improve symptoms of itch and/or pain and/or improve the appearance of dermatofibromas. This is an open-label study where subjects will receive a laser treatment at week 0, and week 4, and then 2 additional follow-up visits. Photographs will be taken at each visit and rated by blinded reviewers after the study to determine efficacy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDermatofibroma of Skin
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 8, 2018
Enrollment StartNov 30, 2017
Primary CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 8.5 years ago

Interventions

1540 nanometer Erbium glass laserdevice

Subjects will receive laser treatment by dermatologist at week 0 and week 4.